|
Vanguard FTSE Developed Markets Index Fund ETF Shares | VEA | SPDR® Dow Jones International Real Estate ETF | RWX | iShares MSCI Australia ETF | EWA | Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares | VSS | Leatherback Long/Short Alternative Yield ETF | LBAY | Vanguard Materials Index Fund ETF Shares | VAW | Texas Instruments Inc | TXN | Sound Enhanced Fixed Income ETF | SDEF | Amplify Seymour Cannabis ETF | CNBS | Changebridge Capital Long/Short Equity ETF | CBLS |
Gross Expense Ratio*
0.05%
SEC 30 Day Yield (as of 12/31/22 )
--
Ann. Dividend/Yield
$1.99/4.34%
Ex-Dividend Date
12/19/2022
52-Wk Range
35.42 - 50.54
Fund Inception
07/20/2007
|
 Loading...
The chart is currently unavailable.
|
The investment seeks to track the performance of the FTSE Developed All Cap ex US Index.The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The adviser attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
|
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Month |
-2.18% |
-2.22% |
-2.18% |
-2.22% |
3-Month |
+16.79% |
+17.11% |
+16.79% |
+17.11% |
6-Month |
+4.39% |
+4.85% |
+4.39% |
+4.85% |
Year-to-date |
-15.36% |
-15.35% |
-15.36% |
-15.35% |
1-Year |
-15.36% |
-15.35% |
-15.36% |
-15.35% |
3-Year |
+1.23% |
+1.35% |
+1.23% |
+1.35% |
5-Year |
+1.63% |
+1.68% |
+1.63% |
+1.68% |
10-Year |
+4.85% |
+4.93% |
+4.85% |
+4.93% |
Since Inception |
+1.88% |
+1.94% |
+1.88% |
+1.94% |
Inception Date: July 20, 2007
Performance Details
Total return reflects performance without adjusting for sales charges or the effects of taxation, but is adjusted to reflect all actual ongoing fund expenses and assumes reinvestment of dividends and capital gains. If adjusted, sales charges would reduce the performance quoted. Performance data quoted represents past performance, is no guarantee of future results, and may not provide an adequate basis for evaluating the performance potential of the product over varying market conditions or economic cycles. Current performance may be higher or lower than the performance data quotes. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.
|
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Year |
-15.36% |
-15.35% |
-15.36% |
-15.35% |
5-Year |
+1.63% |
+1.68% |
+1.63% |
+1.68% |
10-Year |
+4.85% |
+4.93% |
+4.85% |
+4.93% |
Since Inception |
+1.88% |
+1.94% |
+1.88% |
+1.94% |
Inception Date: July 20, 2007
Cyclical |
41.39% |
8.33% |
10.21% |
19.14% |
3.71% |
Defensive |
22.97% |
8.64% |
11.20% |
3.13% |
4.53% |
5.83% |
15.73% |
15.73% |
19.91% |
9.55% |
Portfolio Details
|
Company |
YTD Return (as of 01/27/2023) |
% of Assets |
* Nestle SA |
+1.14% |
1.57% |
* ASML Holding NV |
+22.70% |
1.11% |
* Roche Holding AG |
+1.32% |
1.10% |
* Samsung Electronics Co Ltd |
-- |
1.09% |
* Novo Nordisk A/S Class B |
+2.41% |
1.07% |
* Shell PLC |
+5.42% |
1.01% |
* AstraZeneca PLC |
-4.70% |
1.01% |
* Novartis AG |
-2.01% |
0.92% |
* LVMH Moet Hennessy Louis Vuitton SE |
+19.52% |
0.92% |
* Toyota Motor Corp |
+8.01% |
0.84% |
* represents an International company or one without a recognizable symbol.
Portfolio Details
|
|
|